Lipoprotein-regulating medicants

Details Lipoprotein-regulating medicants Lipoprotein-regulating medicants

2007-05-22

2007-05-22

O'Hara, Eileen (Department: 1646)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C424S422000, C530S350000, C530S399000

Reexamination Certificate

active

10072159

ABSTRACT:
Methods and pharmaceutical compositions useful for treating obesity-related disorders using ApM-1 and related proteins.

REFERENCES:
patent: 6344441 (2002-02-01), Bihain et al.
patent: 6566332 (2003-05-01), Fruebis et al.
patent: 6579852 (2003-06-01), Fruebis et al.
patent: 6635431 (2003-10-01), Bihain et al.
patent: 6867189 (2005-03-01), Lucas et al.
patent: 6946444 (2005-09-01), Bihain et al.
patent: 6967091 (2005-11-01), Fruebis et al.
patent: 2003/0100500 (2003-05-01), Fruebis et al.
patent: 2003/0215836 (2003-11-01), Young et al.
patent: 2003/0224501 (2003-12-01), Young et al.
patent: 2004/0067881 (2004-04-01), Fruebis et al.
patent: 2004/0077051 (2004-04-01), Bihain et al.
patent: 2005/0003997 (2005-01-01), Lucas et al.
patent: 2005/0054565 (2005-03-01), Lucas et al.
patent: 2005/0069971 (2005-03-01), Lucas et al.
patent: 1033134 (2000-09-01), None
patent: WO 96/30400 (1996-10-01), None
patent: WO 96/34981 (1996-11-01), None
patent: WO 96/39429 (1996-12-01), None
patent: WO 97/27286 (1997-07-01), None
patent: WO98/01257 (1998-01-01), None
patent: WO 98/20165 (1998-05-01), None
patent: WO 98/54311 (1998-12-01), None
patent: WO 99/04000 (1999-01-01), None
patent: WO 99/07736 (1999-02-01), None
patent: WO 99/10492 (1999-03-01), None
Fasshauer et al. (2004), Adiponectin, obesity, and cardiovascular disease, Biochimie 86(11): 779-784.
Gil-Campos et al. (2004), Adiponectin, the missing link in insulin resistance and obesity, Clin. Nutr. 23(5): 963-974.
Bays (2004), Current and investigational antiobesity agents and obesity therapeutic treatment targets, Obes. Res. 12(8): 1197-1211.
Hu et al. (1996), AdipoQ is a Novel Adipose-specific Gene Dysregulated in Obesity, J. Biol. Chem. 271(18): 10697-10703.
Maeda et al. (1996), cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (Adipose Most Abundant Gene Transcript 1), Biochem. Biophys. Res. Comm. 221: 286-289.
Scherer et al. (1995), A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes, J. Biol. Chem. 270(45): 26746-26749.
Bowie et al., Science 247: 1306-1310, 1990.
Wells, Biochemistry 29:8509-8517, 1990.
Alexeev and Yoon, “Stable and Inheritable Changes in Genotype and Phenotype of Albino Melanocytes Induced by an RNA-DNA Oligonucleotide”; Nature Biotech., 16:1343-1346, 1998.
Arita, et al., “Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity”, Biochem. and Biophys. Research Comm. 257:79-83, 1999 (Academic Press).
Costal, P., et al., “Peroxisome Proliferator-Activated Receptor a-Isoform Deficiency Leads to Progressive Dyslipidemia With Sexually Dimorphic Obesity and Steatosis”, J. Biol. Chem., vol. 273, No. 45, 29577-29585, Nov. 6, 1998 (The American Society for Biochemistry and Molecular Biology, Inc.).
Imagawa, et al., “Structure-Function Studies of Human Leptin”, J. Biol. Chem., vol. 273, No. 52:35245-35249, Dec. 25, 1998 (The American Society for Biochemistry and Molecular Biology, Inc.).
Kersten, S., et al., “Peroxisome Proliferator?Activated Receptor aMEOIATES the Adaptive Response to Fasting”, J. Clin. Invest, vol. 103, No. 11:1489-1498, Jun. 1999 (The American Society for Clinical Investigations).
Groenen, et al, “Structure, sequence and chromosome 19 localization of human USF2 and its rearrangement in a pateint with multicystic renal adysplasia”,Genomics 38:141-148 (1995), XP002067467.
Saito, et al., “Organization of the Gene for Gelatin-Binding Protein (GBP28)”, Gene, 229:67-73, Jan. 12, 1999 (Elsevier Science B.V.).
Schaffler, et al., “The Human apM-1, An Adipocyte-Specific Gene Linked to the Family of TNF'S and to Genes Expressed in Activated T Cells, is Mapped to Chromosone 1q21.3-q23, A Susceptibility Locus Identified for Familia Combined Hyperlipidaemia (FCH)”, Biochem. and Biophys. Res. Comm. 260:416-425, May 7, 1999 (Academic Press).
Shimomura, et al., “Leptin Reverses Insulin Resistance and Diabetes Mellitus in Mice With Congenital Lipodystrophy”, Nature, 401:73-76, Sep. 2, 1999.
Uotani, S., “Functional Properties of Leptin Receptor Isoforms Internalization and Edgradation of Leptin and Legand-Induced Receptor Downregulation Diabetes”, 48:279-286, Feb. 1999.
Vansant, G., et al., “Determinants of Postprandial Lipernia in Obese Women”, Intl. Jr. of Obesity, 23:Supp. 1, 14-21, 1999 (Stockton Press).
Yen, et al., “Molecular Cloning of a Lipolysis-Stimulated Remnant Receptor Expressed in the Liver”, J. Biol. Chem., vol. 274, #19:13390-13398, 1999 (The American Society for Biochemistry and Molecular Biology, Inc.).
Barsh, G., et al., “Genetics of Body-Weight Regulation”, Nature, vol. 404:644-651, Apr. 6, 2000.
Friedman, J.M., “Obesity in the New Millennium”, Nature, vol. 404:632-634, Apr. 6, 2000 (Macmilan Magazines Ltd.).
Oksana, G., et al., “Hormones: Leptin and Diabetes in Lipoatrophic Mice”, Nature, vol. 403:850, Feb. 24, 2000 (Macmillan Publishers Ltd.).
Oksana, G., et al., “Lack of Responses to a [(Beta).Sub.3]-Adrenergic Agonist in Lipoatrophic A-Zip Mice”, Diabetes, vol. 49, #11:1910, Nov. 2000 (American Diabetes Association).
Hotta, K., et al., “Plasma Concentrations FO a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients”, Arteriosclar Thromb Vasc Biol., 1595-1599, Jun. 2000 (American Heart Association, Inc.).
Kishore, U., et al., “Modular Organization of Proteins Containing Clq-like Globular Domain”, Immunopharmacology 42 (1999) 15-21 (1999 Elsevier Science B.V.).
Kishor, U., et al., “Clq: Structure, Function, and Receptors”, Immunopharmacology 49(2000) 159-170 (2000) Elsevier Science B.V.).
Kopelman, P., “Obesity as a Medical Problem”, Nature, vol. 404:635-643, Apr. 6, 2000 (Macmillan Magazines Ltd.).
Mann, C., et al., “Inhibitory Effects of Specific Apolipoprotein C-III Isoforms on the Binding of Triglyceride-Rich Lipoproteins to the Lipolysis-Stimulated Receptor”, The Journal of Biological Chemistry, vol. 272, #50:31348-31354, 1997 (The American Society for Biochemistry and Molecular Biology, Inc.).
Nakano, Y., et al., “Isolation and Characterization of GBP28, A Novel Gelatin-Binding Purified From Human Plasma”, J. Biochem, vol. 120, #4:803-812 (1996).
Okamoto, Y., et al., “An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular Walls”, Horm Metab Res 2000; 32:47-50 (Georg Thieme Verlag Stuttgart-New York).
Ouchi, N., et al., “Novel Modulator for Endothelial Adhesion Molecules / Adipocyte-Derived Plasma Protein Adiponectin”, Circulation, vol. 100:2473-2476, Dec. 21/28, 1999 (American Heart Association).
Saito, K., et al., “Regulation of Gelatin-Binding Protein 28 (G8P28) Gene Expression by C/EBP”, Biol. Pharm. Bull. 22(11) 1158-1162 (1999).
Shapiro, L., et al., “The Crystal Structure of a Complement-1q Family Protein Suggests an Evolutionary Link to Tumor Necrosis Factor”, Current Biology, vol. 8, No. 6, pp. 335-338.
Takehashi, M., et al., “Genomic Structure and Mutations in Adipose-Specific Gene, Adiponectin”, International Journal of Obesity (2000) 24, 861-868 (Macmillan Publishers Ltd.).
Yokota, T., et al., “Adiponectin, a New Member of the Family of Soluble Defense Collagens, Negatively Regulates the Growth of Myelomonocytic Progenitors and the Functions of Macrophages”, Blood, Sep. 1, 2000—vol. 96, No. 5, pp. 1723-1732 (The American Society of Hematology).
Bihain, B., et al., “The Lipolysis-Stimulated Receptor: A Gene at Last”, Current Opinion in Lipodology, vol. 9, No. 3, pp. 221-224, Jun. 1998.
Bihain, B.E., et al.; “Characterization and purification of the lipolysis-stimulated receptor,” Elsevier Science B.V., pp. 465-470 (1995).
Ghebrehiwet, et al., “Isolation, cDNA Cloning, and Overexpression of a 33-kD Cell Surface Glycoprotein that Binds to the Globu

Affiliated with

Also associated with

Rating

Lipoprotein-regulating medicants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lipoprotein-regulating medicants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipoprotein-regulating medicants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3745694